myeloma

Illustration of two people shaking hands standing on money and a lightbulb

Pharma

Legend Biotech looks to raise $350M amid CAR-T rollout

However, Legend expects its existing cash to fund expenses for “at least the next 12 months.”

Zoey Becker Jul 26, 2022 11:27am

Asia Map

BMS-Eisai, China price cuts, AZ-Hutchmed—Fierce Pharma Asia

Jun 25, 2021 10:50am

Xpovio

Karyopharm snags DLBCL nod for Xpovio

Jun 23, 2020 10:40am

Darzalex Faspro

J&J's Darzalex branches out beyond myeloma with amyloidosis win

Jun 13, 2020 2:30am